Randomized Trial of Active vs Passive Splinting for Extensor Tendon Injuries in Zones IV to VI
NCT ID: NCT06950268
Last Updated: 2025-04-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2020-07-01
2021-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Controlled Active Motion vs Early Passive Mobilization for Flexor Tendons Repair
NCT06420648
Early Mobilization After Volar Plate Osteosynthesis of Distal Radius Fractures
NCT01576224
Conservative Therapy of Proximal Phalanx Fractures - Comparing the Lucerne Cast With Finger Splinting
NCT06022419
Short Forearm Casting Versus Below-elbow Splinting for Acute Immobilization of Distal Radius Fractures
NCT02679066
Inmobilization With Compression Bandage vs Antebraquial Splint in Distal Radius Fractures
NCT06019585
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ICAMS Group
Participants received immediate controlled active motion splinting (ICAMS) after extensor tendon tenorrhaphy. The ICAMS protocol included a daytime yoke splint, which maintained the injured finger in 20° more extension than adjacent fingers, and a nocturnal intrinsic plus static splint. The protocol was maintained for 4 weeks post-surgery
ICAMS Splinting Protocol
The ICAMS protocol consisted of a daytime yoke splint maintaining the injured finger in 20° more extension than adjacent fingers, combined with a nocturnal static splint in the intrinsic plus position. The splinting was applied for 4 weeks following extensor tendon tenorrhaphy.
Classic Immobilization Group
Participants received standard immobilization with a plaster splint in the intrinsic plus position following extensor tendon tenorrhaphy. The immobilization was maintained continuously for 4 weeks.
Classic Plaster Immobilization
Participants received a classic plaster splint in the intrinsic plus position worn continuously for 4 weeks following extensor tendon tenorrhaphy.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ICAMS Splinting Protocol
The ICAMS protocol consisted of a daytime yoke splint maintaining the injured finger in 20° more extension than adjacent fingers, combined with a nocturnal static splint in the intrinsic plus position. The splinting was applied for 4 weeks following extensor tendon tenorrhaphy.
Classic Plaster Immobilization
Participants received a classic plaster splint in the intrinsic plus position worn continuously for 4 weeks following extensor tendon tenorrhaphy.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients from the CHUVI Health Area
* Diagnosed with an acute, single, complete extensor tendon laceration in zones IV, V, or VI of the long fingers
* Treated with primary tenorrhaphy
* Provided signed informed consent
* Agreed to attend follow-up visits and comply with the study protocol
Exclusion Criteria
* Injuries involving the thumb
* Tendon injuries with loss of substance
* Associated injuries at the same level (e.g., bone fracture, nerve lesion)
* Patients with cognitive impairment or inability to follow the protocol
* Presence of other injuries or medical conditions that could interfere with assessment
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fundacin Biomedica Galicia Sur
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Miguel Cela-López, MD
Role: PRINCIPAL_INVESTIGATOR
Sergas
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHUVI Hospital (Complejo Hospitalario Universitario de Vigo)
Vigo, Pontevedra, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020/307
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.